Washington State House of Representatives Office of Program Research | BILL ANALYSIS |
Health Care & Wellness Committee |
HB 2570
This analysis was prepared by non-partisan legislative staff for the use of legislative members in their deliberations. This analysis is not a part of the legislation nor does it constitute a statement of legislative intent. |
Brief Description: Concerning a database of pharmacies offering vaccines and self-administered hormonal contraceptives through collaborative drug therapy agreements.
Sponsors: Representatives Stambaugh, Robinson, Jinkins, Wylie, Muri, Graves, Doglio, Fitzgibbon, Pollet, Hayes, Riccelli and Stonier.
Brief Summary of Bill |
|
Hearing Date: 1/26/18
Staff: Kim Weidenaar (786-7120).
Background:
The Pharmacy Quality Assurance Commission (Commission) regulates the practice of pharmacy and enforces all laws placed under its jurisdiction. A pharmacist is a person properly licensed by the Commission to engage in the practice of pharmacy. The practice of pharmacy includes the initiation or modification of drug therapy in accordance with written guidelines or protocols previously established and approved for the pharmacist's practice by a practitioner authorized to prescribe drugs. The written guideline or protocol, also known as a collaborative drug therapy agreement (CDTA), is defined as an agreement in which any practitioner authorized to prescribe legend drugs delegates to a pharmacist or group of pharmacist's authority to conduct specified prescribing functions. The agreement must include:
the parties subject to the agreement;
a time period not to exceed two years during which the written guidelines or protocol will be in effect;
the type of prescriptive authority decisions which the pharmacist or pharmacists are authorized to make;
in 2016 the Commission was required to develop a sign or sticker to be displayed on the window or door of a pharmacy that initiates or modifies drug therapy related to self-administered contraception.
Summary of Bill:
By July 1, 2019, the Department of Health (DOH) must establish a searchable database available on its website that lists the pharmacies that have one or more pharmacists on staff that have a collaborative drug therapy agreement (CDTA) to prescribe vaccines or self-administered hormonal contraceptives. The data base must include the name and location of the pharmacy and the general types of vaccines or self-administered hormonal contraceptives available through the CDTA. The database must be searchable by zip code and include a map function. It also must be updated quarterly and include a statement that the information is provided for information only and is subject to change.
Pharmacies in the state with one or more pharmacists on staff that prescribe vaccines or hormonal contraceptives through a CDTA must provide the DOH the information necessary for the database, as requested by the DOH.
Appropriation: None.
Fiscal Note: Requested on January 16, 2018.
Effective Date: The bill takes effect 90 days after adjournment of the session in which the bill is passed.